The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Amgen (I); Bristol-Myers Squibb
Stock and Other Ownership Interests - Amgen (I); Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
Neoadjuvant nivolumab (NIVO) + chemotherapy (chemo) vs chemo in patients (pts) with resectable NSCLC: 4-year update from CheckMate 816.
 
Jonathan Spicer
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb/Medarex; Chemocentryx; Merck; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Medarex; Merck; Protalix Biotherapeutics; Regeneron; Xenetic Biosciences
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb/Medarex (Inst); CLS-Therapeutics (Inst); CLS-Therapeutics (Inst); Merck (Inst); Protalix Biotherapeutics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb/Medarex; Merck
 
Nicolas Girard
Employment - AstraZeneca (I)
Consulting or Advisory Role - Abbvie; AMGEN; AstraZeneca; BeiGene; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Ipsen; Janssen; LEO Pharma; Lilly; MSD; Novartis; Pfizer; Roche; Sanofi; Takeda
Research Funding - AstraZeneca (Inst); BMS (Inst); MSDavenir (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; Janssen Oncology; Roche
 
Mariano Provencio
Honoraria - AstraZeneca; BMS; Janssen; Lilly; MSD; Pfizer; Roche; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Janssen Oncology; Lilly; Merck; MSD; Pfizer; Roche; Roche; Takeda
Speakers' Bureau - AstraZeneca; BMS; MSD; Pfizer; Roche; Takeda
Research Funding - AstraZeneca; Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); MSD; Pfizer; Pierre Fabre (Inst); Roche (Inst); Takeda
Travel, Accommodations, Expenses - AstraZeneca; BMS; Boehringer Ingelheim; Bristol Myers Squibb Company; Lilly; MSD; Pierre Fabre; ROCHE; Roche; Takeda
Other Relationship - Pfizer
 
Changli Wang
No Relationships to Disclose
 
Tetsuya Mitsudomi
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Ethicon; Guardant Health; Janssen Oncology; Kyowa Hakko Kirin; Lilly; Merck KGaA; MSD K.K; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda; Thermofisher Scientific Biomarkers
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol Myers Squibb; MSD Oncology; Ono Pharmaceutical; Regeneron
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bridgebio (Inst); Chugai Pharma (Inst); MSD K.K (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst)
 
Mark M. Awad
Consulting or Advisory Role - Affini-T Therapeutics; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; EMD Serono; Foundation Medicine; Gritstone Bio; Instil Bio; Janssen; Merck; Mirati Therapeutics; Novartis; Pfizer; Regeneron
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - Bristol Myers Squibb Foundation
 
Everett E. Vokes
Stock and Other Ownership Interests - Coordination Pharmaceuticals; McKesson
Honoraria - Ascendis Pharma (I)
Consulting or Advisory Role - Ascendis Pharma (I)
Research Funding - Abbvie; Alliance Pharma; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Merck; Novartis
 
Janis M. Taube
Stock and Other Ownership Interests - Akoya Biosciences
Consulting or Advisory Role - Akoya Biosciences; AstraZeneca; Bristol-Myers Squibb; Compugen; Lunaphore Technologies; Merck; Regeneron
Research Funding - Akoya Biosciences (Inst); Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - image processing of multiplex IF/IHC slides (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck
Other Relationship - Akoya Biosciences
 
Lorena Lupinacci
No Relationships to Disclose
 
Gene B. Saylors
No Relationships to Disclose
 
Fumihiro Tanaka
No Relationships to Disclose
 
Moishe Liberman
Stock and Other Ownership Interests - AssistIQ; Ditch Labs; Endocision
Consulting or Advisory Role - Johnson and Johnson
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb/Sanofi (Inst); Cook Medical (Inst); Ethicon/Johnson & Johnson (Inst); Johnson & Johnson/MedTech (Inst); Merck (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Cryobiopsy Device
 
Sung Yong Lee
No Relationships to Disclose
 
Aurelia Alexandru
No Relationships to Disclose
 
Manolo D’Arcangelo
Consulting or Advisory Role - Janssen; Takeda
Travel, Accommodations, Expenses - AstraZeneca; MSD; Roche
 
Phuong Tran
No Relationships to Disclose
 
Javed Mahmood
No Relationships to Disclose
 
Vishwanath Suresh Gharpure
Employment - Bristol-Myers Squibb
 
Apurva Bhingare
No Relationships to Disclose
 
Patrick M. Forde
Consulting or Advisory Role - Amgen; Ascendis Pharma; AstraZeneca/MedImmune; Bristol-Myers Squibb; CureVac; Daiichi Sankyo/UCB Japan; F-Star Biotechnology; Fosun Pharma; G1 Therapeutics; Genelux; Genentech; Gilead Sciences; ITeos Therapeutics; Janssen; Merck; Novartis; Novocure; Regeneron; Sanofi; Synthekine; Teva
Research Funding - AstraZeneca/MedImmune (Inst); BioNTech SE; Bristol-Myers Squibb (Inst); Novartis (Inst); Regeneron